![Michael Webb](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Webb
Vorsitzender bei
ENVERIC BIOSCIENCES, INC.
Vermögen: 18 165 $ am 31.05.2026
Profil
Michael D.
Webb is the founder of Anchor Therapeutics, Inc., founded in 2006.
Current jobs include President, Chief Executive Officer & Director at CXL Ophthalmics LLC since 2017; Chairman at Enveric Biosciences, Inc. since 2022; Director at Deuterx LLC since 2012; Director at iQure Pharma Inc. since 2022; Director at GMDx Genomics since 2021; Director at Videokawa, Inc. since 2018; President at Allegro Diagnostics Corp.
Former jobs include Chief Executive Officer at EPIX Pharmaceuticals, Inc.; President & Chief Executive Officer at CXL Ophthalmics LLC; Executive Chairman at Virtify, Inc.; Chairman at Massachusetts Biotechnology Council; Director at Tyrogenex, Inc.; Member at CEO Roundtable on Cancer, Inc. Education includes undergraduate studies at the University of Kansas, graduate studies at the University of Sussex, and an MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.06.2026 | 7.898 ( 0,21 % ) | 18 165 $ | 31.05.2026 |
Aktive Positionen von Michael Webb
| Unternehmen | Position | Beginn |
|---|---|---|
| ENVERIC BIOSCIENCES, INC. | Vorsitzender | 01.11.2022 |
CXL Ophthalmics LLC
 CXL Ophthalmics LLC Medical/Nursing ServicesHealth Services Develops a treatment for eyecare | Vorstandsvorsitzender | 01.01.2017 |
Iqure Pharma, Inc.
 Iqure Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotech company that develops astrocyte targeted therapeutics to restore glutamate balance in CNS disorders | Direktor/Vorstandsmitglied | 01.01.2022 |
Deuterx LLC
 Deuterx LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company provides drugs for patients | Direktor/Vorstandsmitglied | 01.01.2012 |
Allegro Diagnostics Corp.
 Allegro Diagnostics Corp. Medical/Nursing ServicesHealth Services Develops and commercializes molecular diagnostics system | Präsident | 13.04.2011 |
Ehemalige bekannte Positionen von Michael Webb
| Unternehmen | Position | Ende |
|---|---|---|
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Präsident | 14.09.2005 |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Vorsitzender | - |
CEO Roundtable on Cancer, Inc.
 CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and promoting prevention measures and encouraging early detection through cancer screenings | Corporate Officer/Principal | - |
Virtify, Inc.
 Virtify, Inc. BiotechnologyHealth Technology Provides life sciences solutions | Vorsitzender | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Michael Webb
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
6
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Health Technology |
Anchor Therapeutics, Inc.
 Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Designs and develops peptide modulators of G protein-coupled receptors | Health Technology |
Allegro Diagnostics Corp.
Allegro Diagnostics Corp. Medical/Nursing ServicesHealth Services Develops and commercializes molecular diagnostics system | Health Services |
University of Kansas
 University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Sussex
 University of Sussex Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CEO Roundtable on Cancer, Inc.
CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and promoting prevention measures and encouraging early detection through cancer screenings | Commercial Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
Virtify, Inc.
Virtify, Inc. BiotechnologyHealth Technology Provides life sciences solutions | Health Technology |
Tyrogenex, Inc.
 Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Offers drug discovery and development focused on small molecule kinase inhibitors | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deuterx LLC
Deuterx LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company provides drugs for patients | Health Technology |
Enveric Biosciences, Inc.
 Enveric Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Develops cannabinoid medicines and combination therapies | Health Technology |
CXL Ophthalmics LLC
CXL Ophthalmics LLC Medical/Nursing ServicesHealth Services Develops a treatment for eyecare | Health Services |
Iqure Pharma, Inc.
Iqure Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotech company that develops astrocyte targeted therapeutics to restore glutamate balance in CNS disorders | Health Technology |
